Evidence map›Paper›PMID 34717736›Full record

ArticleTrials2021

Bridging Recovery Initiative Despite Gaps in Entry (BRIDGE): study protocol for a randomized controlled trial of a bridge clinic compared with usual care for patients with opioid use disorder.

David E Marcovitz, Katie D White, William Sullivan, Heather M Limper, Mary Lynn Dear, Reagan Buie, David A Edwards, Cody Chastain, Kristopher A Kast, Christopher J Lindsell and 1 more

Registry-linked trialAbstract readClinical Trial Protocol
In one paragraph

Article in Trials, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04084392 (Evaluating the Impact of the Bridge Clinic in Patients With Opioid Use Disorder), which is not on this map. Cited by 7 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04084392 nacompletednot on this map

Evaluating the Impact of the Bridge Clinic in Patients With Opioid Use Disorder

TypeinterventionalSponsorVanderbilt University Medical CenterRan2019 to 2022Enrolled335ConditionsOpioid Use, Opioid-use DisorderArmsBridge Clinic, Usual Care
3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

David E MarcovitzVanderbilt University Medical Center, Vanderbilt Psychiatric Hospital, 1603 23rd Ave South, Nashville, TN, 37212, USA. david.marcovitz@vumc.org.
Katie D WhiteVanderbilt University Medical Center, Vanderbilt Psychiatric Hospital, 1603 23rd Ave South, Nashville, TN, 37212, USA.
William SullivanVanderbilt University Medical Center, Vanderbilt Psychiatric Hospital, 1603 23rd Ave South, Nashville, TN, 37212, USA.
Heather M LimperVanderbilt University Medical Center, Vanderbilt Psychiatric Hospital, 1603 23rd Ave South, Nashville, TN, 37212, USA.
Mary Lynn DearVanderbilt University Medical Center, Vanderbilt Psychiatric Hospital, 1603 23rd Ave South, Nashville, TN, 37212, USA.
Reagan BuieVanderbilt University Medical Center, Vanderbilt Psychiatric Hospital, 1603 23rd Ave South, Nashville, TN, 37212, USA.
David A EdwardsVanderbilt University Medical Center, Vanderbilt Psychiatric Hospital, 1603 23rd Ave South, Nashville, TN, 37212, USA.
Cody ChastainVanderbilt University Medical Center, Vanderbilt Psychiatric Hospital, 1603 23rd Ave South, Nashville, TN, 37212, USA.
Kristopher A KastVanderbilt University Medical Center, Vanderbilt Psychiatric Hospital, 1603 23rd Ave South, Nashville, TN, 37212, USA.
Christopher J LindsellVanderbilt University Medical Center, Vanderbilt Psychiatric Hospital, 1603 23rd Ave South, Nashville, TN, 37212, USA.
Vanderbilt Learning Health System Investigators

Funding

Vanderbilt Institute for Clinical and Translational Research (VICTR) -Identifying correlates of functional immunity in SARS-CoV-2 convalescent plasmaUL1TR002243 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Paul A. Harris, Wesley H Self · 2017 to 2026
$130.7M
NCATS NIH HHS UL1 TR002243
6 · The paper itself

Abstract

backgroundPatients with substance use disorders are overrepresented among general hospital inpatients, and their admissions are associated with longer lengths of stay and increased readmission rates. Amid the national opioid crisis, increased attention has been given to the integration of addiction with routine medical care in order to better engage such patients and minimize fragmentation of care. General hospital addiction consultation services and transitional, hospital-based "bridge" clinics have emerged as potential solutions. We designed the Bridging Recovery Initiative Despite Gaps in Entry (BRIDGE) trial to determine if these clinics are superior to usual care for these patients.

methodsThis single-center, pragmatic, randomized controlled clinical trial is enrolling hospitalized patients with opioid use disorder (OUD) who are initiating medication for OUD (MOUD) in consultation with the addiction consult service. Patients are randomized for referral to a co-located, transitional, multidisciplinary bridge clinic or to usual care, with the assignment probability being determined by clinic capacity. The primary endpoint is hospital length of stay. Secondary endpoints include quality of life, linkage to care, self-reported buprenorphine or naltrexone fills, rate of known recurrent opioid use, readmission rates, and costs. Implementation endpoints include willingness to be referred to the bridge clinic, attendance rates among those referred, and reasons why patients were not eligible for referral. The main analysis will use an intent-to-treat approach with full covariate adjustment. DISCUSSION: This ongoing pragmatic trial will provide evidence on the effectiveness of proactive linkage to a bridge clinic intervention for hospitalized patients with OUD initiating evidence-based pharmacotherapy in consultation with the addiction consult service.

trial registrationClinicalTrials.gov NCT04084392 . Registered on 10 September 2019. The study has been approved by the Vanderbilt Institutional Review Board. The current approved protocol is dated version May 12, 2021.

Indexed as

BuprenorphineOpioid-Related DisordersHumansNaltrexonePragmatic Clinical Trials as TopicQuality of LifeRandomized Controlled Trials as TopicReferral and ConsultationBuprenorphineNaltrexoneBridge clinicOpioid use disorderPragmatic clinical trialSubstance use disorder

Identifiers

PMID34717736
PMCPMC8556830

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.